Shuttle Pharmaceuticals Q3 2023 EPS $(0.11) Down From $(0.10) YoY
Portfolio Pulse from Benzinga Newsdesk
Shuttle Pharmaceuticals reported a Q3 2023 EPS of $(0.11), a decrease from the $(0.10) reported in the same quarter of the previous year.
November 14, 2023 | 2:14 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Shuttle Pharmaceuticals reported a year-over-year decrease in earnings per share for Q3 2023, with EPS falling to $(0.11) from $(0.10).
A decrease in EPS typically indicates a reduction in profitability, which can lead to negative investor sentiment and a potential decrease in stock price in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100